Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Lung Cancer

Free Subscription Articles published in J Thorac Oncol Retrieve available abstracts of 127 articles: HTML format

Single Articles

June 2008
1. GIOVANNINI M , Belli C, Villa E, Gregorc V, et al
   Estrogen receptor (ER) and epidermal growth factor receptor (EGFR) as targets for dual lung cancer therapy: not just a case?
   J Thorac Oncol. 2008;3:684-5.
   PubMed     Related articles   
   
   
   
2. PANT-PUROHIT M , Cheng L, Einhorn L
   Apparent surgical cure for metastatic small cell lung cancer.
   J Thorac Oncol. 2008;3:682-3.
   PubMed     Related articles   
   
   
   
3. KELLY K , Huang C
   Biological agents in non-small cell lung cancer: a review of recent advances and clinical results with a focus on epidermal growth factor receptor and vascular endothelial growth factor.
   J Thorac Oncol. 2008;3:664-73.
   PubMed     Related articles    Abstract available
   
   
   
4. DECLERCQ I , Lievens Y, Verbeken E, Vansteenkiste J, et al
   Image of the month. Rash in a patient treated with pemetrexed for relapsed non-small cell lung cancer.
   J Thorac Oncol. 2008;3:662-3.
   PubMed     Related articles   
   
   
   
5. MANAPOV F , Klautke G, Fietkau R
   Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience.
   J Thorac Oncol. 2008;3:652-5.
   PubMed     Related articles    Abstract available
   
   
   
6. HUGHES S , Liong J, Miah A, Ahmad S, et al
   A brief report on the safety study of induction chemotherapy followed by synchronous radiotherapy and cetuximab in stage III non-small cell lung cancer (NSCLC): SCRATCH study.
   J Thorac Oncol. 2008;3:648-51.
   PubMed     Related articles    Abstract available
   
   
   
7. LI T , Ling YH, Perez-Soler R
   Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR gene.
   J Thorac Oncol. 2008;3:643-7.
   PubMed     Related articles    Abstract available
   
   
   
8. SETO T , Yamanaka T, Nakano M, Ota M, et al
   Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum.
   J Thorac Oncol. 2008;3:637-42.
   PubMed     Related articles    Abstract available
   
   
   
9. MAUER AM , Cohen EE, Ma PC, Kozloff MF, et al
   A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.
   J Thorac Oncol. 2008;3:631-6.
   PubMed     Related articles    Abstract available
   
   
   
10. LANGER CJ , O'Byrne KJ, Socinski MA, Mikhailov SM, et al
    Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:623-30.
    PubMed     Related articles    Abstract available
    
    
    
11. NAITO Y , Kubota K, Nihei K, Fujii T, et al
    Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer.
    J Thorac Oncol. 2008;3:617-22.
    PubMed     Related articles    Abstract available
    
    
    
12. YAMASHITA Y , Kataoka K, Ishida T, Matsuura M, et al
    A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancer.
    J Thorac Oncol. 2008;3:612-6.
    PubMed     Related articles    Abstract available
    
    
    
13. JIANG F , Xu L, Yuan FL, Huang JF, et al
    Lung autotransplantation technique in the treatment for central lung cancer of upper lobe.
    J Thorac Oncol. 2008;3:609-11.
    PubMed     Related articles    Abstract available
    
    
    
14. BALDUYCK B , Hendriks J, Lauwers P, Van Schil P, et al
    Quality of life after lung cancer surgery: a prospective pilot study comparing bronchial sleeve lobectomy with pneumonectomy.
    J Thorac Oncol. 2008;3:604-8.
    PubMed     Related articles    Abstract available
    
    
    
15. KAWAGUCHI T , Watanabe S, Kawachi R, Suzuki K, et al
    The impact of residual tumor morphology on prognosis, recurrence, and fistula formation after lung cancer resection.
    J Thorac Oncol. 2008;3:599-603.
    PubMed     Related articles    Abstract available
    
    
    
16. CEPPI P , Longo M, Volante M, Novello S, et al
    Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study.
    J Thorac Oncol. 2008;3:583-9.
    PubMed     Related articles    Abstract available
    
    
    
17. WRIGHT CM , Bowman RV, Tan ME, Martins MU, et al
    Lung asbestos content in lungs resected for primary lung cancer.
    J Thorac Oncol. 2008;3:569-76.
    PubMed     Related articles    Abstract available
    
    
    
18. ZHANG H , Hyrien O, Pandya KJ, Keng PC, et al
    Tumor response kinetics after schedule-dependent paclitaxel chemoradiation treatment for inoperable non-small cell lung cancer: a model for low-dose chemotherapy radiosensitization.
    J Thorac Oncol. 2008;3:563-8.
    PubMed     Related articles    Abstract available
    
    
    May 2008
19. EINHORN LH , Bonomi P, Bunn PA Jr, Camidge DR, et al
    Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer.
    J Thorac Oncol. 2008;3:545-55.
    PubMed     Related articles   
    
    
    
20. KASED N , Erasmus JJ, Komaki R, Cox JD, et al
    Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review.
    J Thorac Oncol. 2008;3:534-8.
    PubMed     Related articles    Abstract available
    
    
    
21. LILENBAUM R , Raez L, Tseng J, Seigel L, et al
    Efficacy and safety of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:511-5.
    PubMed     Related articles    Abstract available
    
    
    
22. PALLIS AG , Polyzos A, Boukovinas I, Agelidou A, et al
    Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: the Hellenic Oncology Research Group experience.
    J Thorac Oncol. 2008;3:505-10.
    PubMed     Related articles    Abstract available
    
    
    
23. ERRIDGE SC , Murray B, Price A, Ironside J, et al
    Improved treatment and survival for lung cancer patients in South-East Scotland.
    J Thorac Oncol. 2008;3:491-8.
    PubMed     Related articles    Abstract available
    
    
    
24. SEKI N , Sawada S, Nakata M, Inoue T, et al
    Lung cancer with localized ground-glass attenuation represents early-stage adenocarcinoma in nonsmokers.
    J Thorac Oncol. 2008;3:483-90.
    PubMed     Related articles    Abstract available
    
    
    
25. KUYAMA S , Hotta K, Tabata M, Segawa Y, et al
    Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:477-82.
    PubMed     Related articles    Abstract available
    
    
    
26. MACBETH F
    Measuring the outcomes of lung cancer treatment.
    J Thorac Oncol. 2008;3:455-6.
    PubMed     Related articles   
    
    
    April 2008
27. LUDOVINI V , Gori S, Pistola L, Fazia MA, et al
    Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation.
    J Thorac Oncol. 2008;3:452-3.
    PubMed     Related articles   
    
    
    
28. DUDEK AZ , Chereddy S, Nguyen S, Wagner JE, et al
    Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.
    J Thorac Oncol. 2008;3:447-50.
    PubMed     Related articles    Abstract available
    
    
    
29. GRIDELLI C , Ardizzoni A, Ciardiello F, Hanna N, et al
    Second-line treatment of advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:430-40.
    PubMed     Related articles    Abstract available
    
    
    
30. SCHULTZ EM , Silvestri GA, Gould MK
    Variation in experts' beliefs about lung cancer growth, progression, and prognosis.
    J Thorac Oncol. 2008;3:422-6.
    PubMed     Related articles    Abstract available
    
    
    
31. GOTO Y , Sekine I, Yamada K, Nokihara H, et al
    Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients.
    J Thorac Oncol. 2008;3:412-6.
    PubMed     Related articles    Abstract available
    
    
    
32. CORTINOVIS D , Bidoli P, Cullura D, Lorusso V, et al
    Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?
    J Thorac Oncol. 2008;3:405-11.
    PubMed     Related articles    Abstract available
    
    
    
33. WONG AS , Soong R, Seah SB, Lim SW, et al
    Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer.
    J Thorac Oncol. 2008;3:400-4.
    PubMed     Related articles    Abstract available
    
    
    
34. DUDEK AZ , Larson T, McCleod MJ, Schneider DJ, et al
    Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer.
    J Thorac Oncol. 2008;3:394-9.
    PubMed     Related articles    Abstract available
    
    
    
35. KIURA K , Nakagawa K, Shinkai T, Eguchi K, et al
    A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer.
    J Thorac Oncol. 2008;3:386-93.
    PubMed     Related articles    Abstract available
    
    
    
36. AGARWALA A , Fisher W, Bruetman D, McClean J, et al
    Gefitinib plus celecoxib in chemotherapy-naive patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group.
    J Thorac Oncol. 2008;3:374-9.
    PubMed     Related articles    Abstract available
    
    
    
37. LUDOVINI V , Pistola L, Gregorc V, Floriani I, et al
    Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    J Thorac Oncol. 2008;3:365-73.
    PubMed     Related articles    Abstract available
    
    
    
38. MAROM EM , Martinez CH, Truong MT, Lei X, et al
    Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer.
    J Thorac Oncol. 2008;3:351-7.
    PubMed     Related articles    Abstract available
    
    
    
39. BEAU-FALLER M , Ruppert AM, Voegeli AC, Neuville A, et al
    MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naive cohort.
    J Thorac Oncol. 2008;3:331-9.
    PubMed     Related articles    Abstract available
    
    
    
40. 
    Abstracts of the International Association for the Study of Lung Cancer.
    J Thorac Oncol. 2008;3.
    PubMed     Related articles   
    
    
    
41. WU SG , Shih JY, Yu CJ, Yang PC, et al
    Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation.
    J Thorac Oncol. 2008;3:451-2.
    PubMed     Related articles   
    
    
    
42. CHO S , Ra YJ, Lee CT, Chung JH, et al
    Difficulties in diagnosis and management of ectopic Cushing syndrome.
    J Thorac Oncol. 2008;3:444-6.
    PubMed     Related articles    Abstract available
    
    
    
43. LONGO M , Levra MG, Capelletto E, Bille A, et al
    Fetal adenocarcinoma of the lung in a 25-year-old woman.
    J Thorac Oncol. 2008;3:441-3.
    PubMed     Related articles    Abstract available
    
    
    
44. EMBLEY MA , Fairbairn IP
    Endobronchial tumor migration presenting with acute breathlessness and stridor.
    J Thorac Oncol. 2008;3:428-9.
    PubMed     Related articles    Abstract available
    
    
    
45. CRISTEA MC , Venkataraman K
    Left atrial mass.
    J Thorac Oncol. 2008;3:427.
    PubMed     Related articles   
    
    
    
46. PARIKH P , Chang AY, Nag S, Digumarti R, et al
    Clinical experience with gefitinib in Indian patients.
    J Thorac Oncol. 2008;3:380-5.
    PubMed     Related articles    Abstract available
    
    
    
47. MORI T , Nomori H, Ikeda K, Kawanaka K, et al
    Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.
    J Thorac Oncol. 2008;3:358-64.
    PubMed     Related articles    Abstract available
    
    
    
48. SOH J , Toyooka S, Ichihara S, Asano H, et al
    Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung.
    J Thorac Oncol. 2008;3:340-7.
    PubMed     Related articles    Abstract available
    
    
    
49. JI L , Roth JA
    Tumor suppressor FUS1 signaling pathway.
    J Thorac Oncol. 2008;3:327-30.
    PubMed     Related articles    Abstract available
    
    
    March 2008
50. SCULIER JP , Meert AP
    Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis.
    J Thorac Oncol. 2008;3:320.
    PubMed     Related articles   
    
    
    
51. STINCHCOMBE TE , Fried DB, Baggstrom MQ, Hensing TA, et al
    Third-Generation Chemotherapy Agents in the Treatment of Advanced Non-small Cell Lung Cancer: A Meta-Analysis.
    J Thorac Oncol. 2008;3:320-322.
    PubMed     Related articles   
    
    
    
52. RAJ JV , Coulden R, Entwisle J
    IASLC Lung Cancer Staging Project--a radiologist perspective.
    J Thorac Oncol. 2008;3:318-9.
    PubMed     Related articles   
    
    
    
53. BARBIERI V , Tassone P, Tagliaferri P
    The IASLC Lung Cancer Staging Project: revision proposal of pleural effusion and controlateral nodule staging.
    J Thorac Oncol. 2008;3:317.
    PubMed     Related articles   
    
    
    
54. RAMI-PORTA R , Postmus PE, Goldstraw P
    Reply to the Letter to the Editor Entitled The IASLC Lung Cancer Staging Project: Revision Proposal of Pleural Effusion and Contralateral Nodule Staging, by V. Barbieri, P. Tassone, and P. Tagliaferri.
    J Thorac Oncol. 2008;3:317-318.
    PubMed     Related articles   
    
    
    
55. BRUECKL WM , Schoeberl A, Wirtz RM, Murray S, et al
    Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).
    J Thorac Oncol. 2008;3:314-6.
    PubMed     Related articles    Abstract available
    
    
    
56. FONG T , Morgensztern D, Govindan R
    EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:303-10.
    PubMed     Related articles    Abstract available
    
    
    
57. DETTERBECK F
    What to do with "Surprise" N2?: intraoperative management of patients with non-small cell lung cancer.
    J Thorac Oncol. 2008;3:289-302.
    PubMed     Related articles    Abstract available
    
    
    
58. RAMALINGAM S , Forster J, Naret C, Evans T, et al
    Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal antibody, and gefitinib, a tyrosine kinase inhibitor, in patients with refractory non-small cell lung cancer (NSCLC): a phase I study.
    J Thorac Oncol. 2008;3:258-64.
    PubMed     Related articles    Abstract available
    
    
    
59. STINCHCOMBE TE , Morris DE, Lee CB, Moore DT, et al
    Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small c
    J Thorac Oncol. 2008;3:250-7.
    PubMed     Related articles    Abstract available
    
    
    
60. TOURNOY KG , Ryck FD, Vanwalleghem L, Praet M, et al
    The yield of endoscopic ultrasound in lung cancer staging: does lymph node size matter?
    J Thorac Oncol. 2008;3:245-9.
    PubMed     Related articles    Abstract available
    
    
    
61. STEVENS W , Stevens G, Kolbe J, Cox B, et al
    Ethnic differences in the management of lung cancer in New Zealand.
    J Thorac Oncol. 2008;3:237-44.
    PubMed     Related articles    Abstract available
    
    
    
62. HIRSH V , Major PP, Lipton A, Cook RJ, et al
    Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity.
    J Thorac Oncol. 2008;3:228-36.
    PubMed     Related articles    Abstract available
    
    
    
63. OU SH , Zell JA
    Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
    J Thorac Oncol. 2008;3:216-27.
    PubMed     Related articles    Abstract available
    
    
    
64. QIAN J , Massion PP
    Role of chromosome 3q amplification in lung cancer.
    J Thorac Oncol. 2008;3:212-5.
    PubMed     Related articles    Abstract available
    
    
    
65. SAKAKIBARA T , Saijo Y, Fukuhara T, Gomi K, et al
    Adenocarcinoma with epidermal growth factor receptor gene mutations in three siblings.
    J Thorac Oncol. 2008;3:311-3.
    PubMed     Related articles    Abstract available
    
    
    
66. SANO Y , Kanazawa S, Mimura H, Gobara H, et al
    A novel strategy for treatment of metastatic pulmonary tumors: radiofrequency ablation in conjunction with surgery.
    J Thorac Oncol. 2008;3:283-8.
    PubMed     Related articles    Abstract available
    
    
    
67. ONUKI T , Ishikawa S, Yamamoto T, Ito H, et al
    Pathologic radioresponse of preoperatively irradiated invasive thymomas.
    J Thorac Oncol. 2008;3:270-6.
    PubMed     Related articles    Abstract available
    
    
    
68. HILLERDAL G
    Indolent lung cancers--time for a paradigm shift: a review.
    J Thorac Oncol. 2008;3:208-11.
    PubMed     Related articles    Abstract available
    
    
    February 2008
69. PARK GM , Han KS, Chang YH, Kim CH, et al
    Immune hemolytic anemia after treatment with pemetrexed for lung cancer.
    J Thorac Oncol. 2008;3:196-7.
    PubMed     Related articles   
    
    
    
70. JONES LW , Eves ND, Mackey JR, Peddle CJ, et al
    Systemic inflammation, cardiorespiratory fitness, and quality of life in patients with advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:194-5.
    PubMed     Related articles   
    
    
    
71. VIDAVER RM , Schachter BS
    2007 Annual Meeting of the National Lung Cancer Partnership: a summary of meeting highlights.
    J Thorac Oncol. 2008;3:190-3.
    PubMed     Related articles    Abstract available
    
    
    
72. CHANG JY , Dong L, Liu H, Starkschall G, et al
    Image-guided radiation therapy for non-small cell lung cancer.
    J Thorac Oncol. 2008;3:177-86.
    PubMed     Related articles    Abstract available
    
    
    
73. DECOSTER L , Stroobants S, Verbeken E, Nackaerts K, et al
    An unexpected abdominal 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) in a patient with limited stage small cell lung cancer.
    J Thorac Oncol. 2008;3:174-6.
    PubMed     Related articles    Abstract available
    
    
    
74. FROESCHL S , Nicholas G, Gallant V, Laurie SA, et al
    Outcomes of second-line chemotherapy in patients with relapsed extensive small cell lung cancer.
    J Thorac Oncol. 2008;3:163-9.
    PubMed     Related articles    Abstract available
    
    
    
75. GRAZIANO SL , Herndon JE 2nd, Socinski MA, Wang X, et al
    Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901.
    J Thorac Oncol. 2008;3:158-62.
    PubMed     Related articles    Abstract available
    
    
    
76. GOTTFRIED M , Ramlau R, Krzakowski M, Ziolo G, et al
    Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results.
    J Thorac Oncol. 2008;3:152-7.
    PubMed     Related articles    Abstract available
    
    
    
77. STINCHCOMBE TE , Harper HD, Hensing TA, Moore DT, et al
    The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer.
    J Thorac Oncol. 2008;3:145-51.
    PubMed     Related articles    Abstract available
    
    
    
78. JENA A , Taneja S, Talwar V, Sharma JB, et al
    Magnetic resonance (MR) patterns of brain metastasis in lung cancer patients: correlation of imaging findings with symptom.
    J Thorac Oncol. 2008;3:140-4.
    PubMed     Related articles    Abstract available
    
    
    
79. MORGENSZTERN D , Goodgame B, Baggstrom MQ, Gao F, et al
    The effect of FDG-PET on the stage distribution of non-small cell lung cancer.
    J Thorac Oncol. 2008;3:135-9.
    PubMed     Related articles    Abstract available
    
    
    
80. GOODGAME B , Pillot GA, Yang Z, Shriki J, et al
    Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer.
    J Thorac Oncol. 2008;3:130-4.
    PubMed     Related articles    Abstract available
    
    
    
81. LILENBAUM RC , Cashy J, Hensing TA, Young S, et al
    Prevalence of poor performance status in lung cancer patients: implications for research.
    J Thorac Oncol. 2008;3:125-9.
    PubMed     Related articles    Abstract available
    
    
    
82. RECKAMP KL , Gardner BK, Figlin RA, Elashoff D, et al
    Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin.
    J Thorac Oncol. 2008;3:117-24.
    PubMed     Related articles    Abstract available
    
    
    
83. CARDEN CP , O'Brien ME
    Small-cell lung cancer, getting smaller but still difficult to treat.
    J Thorac Oncol. 2008;3:103-4.
    PubMed     Related articles   
    
    
    
84. HOWE KL , Leighl NB
    Factors contributing to adjuvant therapy decisions.
    J Thorac Oncol. 2008;3:195-6.
    PubMed     Related articles   
    
    
    
85. SOS ML , Zander T, Thomas RK, Staratschek-Jox A, et al
    Expression of signaling mediators downstream of EGF-receptor predict sensitivity to small molecule inhibitors directed against the EGF-receptor pathway.
    J Thorac Oncol. 2008;3:170-3.
    PubMed     Related articles    Abstract available
    
    
    
86. MARKS JL , Broderick S, Zhou Q, Chitale D, et al
    Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.
    J Thorac Oncol. 2008;3:111-6.
    PubMed     Related articles    Abstract available
    
    
    
87. KRYSAN K , Lee JM, Dohadwala M, Gardner BK, et al
    Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance.
    J Thorac Oncol. 2008;3:107-10.
    PubMed     Related articles    Abstract available
    
    
    
88. MOK TS , Crowley J
    Big question, small answer.
    J Thorac Oncol. 2008;3:105-6.
    PubMed     Related articles   
    
    
    January 2008
89. AZZOLI CG , Park BJ, Pao W, Zakowski M, et al
    Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer: a time for excitement and equipoise.
    J Thorac Oncol. 2008;3:84-93.
    PubMed     Related articles    Abstract available
    
    
    
90. DAVIES AM , Ruel C, Lara PN, Lau DH, et al
    The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.
    J Thorac Oncol. 2008;3:68-74.
    PubMed     Related articles    Abstract available
    
    
    
91. CHOONG NW , Vokes EE, Haraf DJ, Tothy PK, et al
    Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
    J Thorac Oncol. 2008;3:59-67.
    PubMed     Related articles    Abstract available
    
    
    
92. ASAMURA H , Goya T, Koshiishi Y, Sohara Y, et al
    A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.
    J Thorac Oncol. 2008;3:46-52.
    PubMed     Related articles    Abstract available
    
    
    
93. DETTERBECK FC , Socinski MA, Gralla RJ, Edelman MJ, et al
    Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
    J Thorac Oncol. 2008;3:37-45.
    PubMed     Related articles    Abstract available
    
    
    
94. DE MARINIS F , Pereira JR, Fossella F, Perry MC, et al
    Lung Cancer Symptom Scale outcomes in relation to standard efficacy measures: an analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:30-6.
    PubMed     Related articles    Abstract available
    
    
    
95. DU W , Mood D, Gadgeel S, Simon MS, et al
    An educational video to increase clinical trials enrollment among lung cancer patients.
    J Thorac Oncol. 2008;3:23-9.
    PubMed     Related articles    Abstract available
    
    
    
96. BOZZETTI C , Tiseo M, Lagrasta C, Nizzoli R, et al
    Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites.
    J Thorac Oncol. 2008;3:18-22.
    PubMed     Related articles    Abstract available
    
    
    
97. BERGHMANS T , Dusart M, Paesmans M, Hossein-Foucher C, et al
    Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European L
    J Thorac Oncol. 2008;3:6-12.
    PubMed     Related articles    Abstract available
    
    
    
98. PETRELLA F , Leo F, Veronesi G, Solli P, et al
    "Salvage" surgery for primary mediastinal malignancies: is it worthwhile?
    J Thorac Oncol. 2008;3:53-8.
    PubMed     Related articles    Abstract available
    
    
    
99. INAMURA K , Takeuchi K, Togashi Y, Nomura K, et al
    EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.
    J Thorac Oncol. 2008;3:13-7.
    PubMed     Related articles    Abstract available
    
    
    December 2007
100. VAN MEERBEECK JP , Van Schil PE, Senan S
     Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer.
     J Thorac Oncol. 2007;2:1138-9.
     PubMed     Related articles   
     
     
     
101. DIZDAR O , Harputluoglu H, Dede DS, Altundag K, et al
     Adjuvant use of epidermal growth factor receptor kinase inhibitors may prevent bone metastases in patients with non-small cell lung carcinoma.
     J Thorac Oncol. 2007;2:1136.
     PubMed     Related articles   
     
     
     
102. COSTA DB , Kobayashi S, Schumer ST
     Erlotinib-associated alopecia in a lung cancer patient.
     J Thorac Oncol. 2007;2:1136-8.
     PubMed     Related articles   
     
     
     
103. RIMNER A , Rosenzweig KE
     Palliative radiation for lung cancer metastases to the breast: two case reports.
     J Thorac Oncol. 2007;2:1133-5.
     PubMed     Related articles    Abstract available
     
     
     
104. ROENHORST AW , van den Bergh AC, van Putten JW, Smit EF, et al
     Iris metastasis in small-cell lung carcinoma.
     J Thorac Oncol. 2007;2:1128-9.
     PubMed     Related articles    Abstract available
     
     
     
105. DAVIES AM , Ho C, Metzger AS, Beckett LA, et al
     Phase I study of two different schedules of bortezomib and pemetrexed in advanced solid tumors with emphasis on non-small cell lung cancer.
     J Thorac Oncol. 2007;2:1112-6.
     PubMed     Related articles    Abstract available
     
     
     
106. HOANG JK , Patz E Jr, Giroux D, Goldstraw P, et al
     Frequency and prognostic significance of preoperatively detected enlarged regional lymph nodes in patients with pathological stage I non-small cell lung cancer following resection.
     J Thorac Oncol. 2007;2:1103-6.
     PubMed     Related articles    Abstract available
     
     
     
107. TANVETYANON T , Soares HP, Djulbegovic B, Jacobsen PB, et al
     A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.
     J Thorac Oncol. 2007;2:1091-7.
     PubMed     Related articles    Abstract available
     
     
     
108. ZELL JA , Ignatius Ou SH, Ziogas A, Anton-Culver H, et al
     Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry.
     J Thorac Oncol. 2007;2:1078-85.
     PubMed     Related articles    Abstract available
     
     
     
109. SHEPHERD FA , Crowley J, Van Houtte P, Postmus PE, et al
     The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.
     J Thorac Oncol. 2007;2:1067-77.
     PubMed     Related articles    Abstract available
     
     
     
110. SAKAO Y , Miyamoto H, Oh S, Takahashi N, et al
     Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement.
     J Thorac Oncol. 2007;2:1107-11.
     PubMed     Related articles    Abstract available
     
     
     
111. MATSUOKA K , Sumitomo S, Misaki N
     Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung.
     J Thorac Oncol. 2007;2:1098-102.
     PubMed     Related articles    Abstract available
     
     
     
112. BOLDRINI L , Gisfredi S, Ursino S, Camacci T, et al
     Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.
     J Thorac Oncol. 2007;2:1086-90.
     PubMed     Related articles    Abstract available
     
     
     
113. ROSELL R , Mendez P, Isla D, Taron M, et al
     Platinum resistance related to a functional NER pathway.
     J Thorac Oncol. 2007;2:1063-6.
     PubMed     Related articles   
     
     
     November 2007
114. SATOH H , Ohara G, Hizawa N
     Primary synovial sarcoma of the chest wall.
     J Thorac Oncol. 2007;2:1060.
     PubMed     Related articles   
     
     
     
115. KOHMO S , Tachibana I, Osaki T, Goya S, et al
     Multiple organ mucosa-associated lymphoid tissue lymphoma presenting with lymphangitic pattern of spread in the lung.
     J Thorac Oncol. 2007;2:1057-9.
     PubMed     Related articles   
     
     
     
116. CASALI C , Rossi G, Siopis E, Fontana G, et al
     Paraffinoma and carcinoid tumorlet: a hitherto unreported association mimicking lung cancer.
     J Thorac Oncol. 2007;2:1052-3.
     PubMed     Related articles   
     
     
     
117. CHOROSTOWSKA-WYNIMKO J , Szpechcinski A
     The impact of genetic markers on the diagnosis of lung cancer: a current perspective.
     J Thorac Oncol. 2007;2:1044-51.
     PubMed     Related articles    Abstract available
     
     
     
118. FUJII M , Kiura K, Takigawa N, Takeda H, et al
     Super scan using positron emission tomography in lung cancer patients.
     J Thorac Oncol. 2007;2:1042-3.
     PubMed     Related articles   
     
     
     
119. PANDYA KJ , Dahlberg S, Hidalgo M, Cohen RB, et al
     A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500
     J Thorac Oncol. 2007;2:1036-41.
     PubMed     Related articles    Abstract available
     
     
     
120. OXNARD GR , Fidias P, Muzikansky A, Sequist LV, et al
     Non-small cell lung cancer in octogenarians: treatment practices and preferences.
     J Thorac Oncol. 2007;2:1029-35.
     PubMed     Related articles    Abstract available
     
     
     
121. YENDAMURI S , Komaki RR, Correa AM, Allen P, et al
     Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer.
     J Thorac Oncol. 2007;2:1022-8.
     PubMed     Related articles    Abstract available
     
     
     
122. ILIC N , Petricevic A, Arar D, Kotarac S, et al
     Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.
     J Thorac Oncol. 2007;2:1018-21.
     PubMed     Related articles    Abstract available
     
     
     
123. BROKX HA , Visser O, Postmus PE, Paul MA, et al
     Surgical treatment for octogenarians with lung cancer: results from a population-based series of 124 patients.
     J Thorac Oncol. 2007;2:1013-7.
     PubMed     Related articles    Abstract available
     
     
     
124. DE JONG WK , van der Heijden HF, Pruim J, Dalesio O, et al
     Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
     J Thorac Oncol. 2007;2:1007-12.
     PubMed     Related articles    Abstract available
     
     
     
125. LO DS , Zeldin RA, Skrastins R, Fraser IM, et al
     Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis.
     J Thorac Oncol. 2007;2:1001-6.
     PubMed     Related articles    Abstract available
     
     
     
126. KEMP RA , Reinders DM, Turic B
     Detection of lung cancer by automated sputum cytometry.
     J Thorac Oncol. 2007;2:993-1000.
     PubMed     Related articles    Abstract available
     
     
     
127. NEMENOFF RA
     Peroxisome proliferator-activated receptor-gamma in lung cancer: defining specific versus "off-target" effectors.
     J Thorac Oncol. 2007;2:989-92.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: